KZA 2.17% $1.35 kazia therapeutics limited

shaw report re novogen patent

  1. 12,411 Posts.
    lightbulb Created with Sketch. 194
    7. Novogen Limited (NRT) said today that a licensee of one of its patents has sued another company, claiming that that company's products infringe its patent rights. The licensee, The Solae Co, has rights in relation to Novogen's recently granted United States patent, which covers the use of certain isoflavones for the teartment of menopausal symptoms. The Solae Co has filed a suit against Archer Daniel Midland Co (ADM) and Amerifit Nutrition Inc, claiming that ADM's Novasoy isoflavone products and the Estroven health supplement products marketed by Amerifit infringe certain patent rights of Solae. Novogen managing director Christopher Naughton said the inclusion of Novogen's US patent in the action confirmed the commercial utility of the company's expanding intellectual property portfolio. (AAP)
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Mkt cap ! $178.8M
Open High Low Value Volume
$1.38 $1.38 $1.35 $87K 63.67K

Buyers (Bids)

No. Vol. Price($)
1 7222 $1.35

Sellers (Offers)

Price($) Vol. No.
$1.35 2427 1
View Market Depth
Last trade - 10.16am 07/05/2021 (20 minute delay) ?
-0.030 ( 0.00 %)
Open High Low Volume
$1.38 $1.38 $1.38 3450
Last updated 10.28am 07/05/2021 (live) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.